I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Gallamini, Andrea
122
results:
Search for persons
X
Format
Online (122)
Mediatypes
Articles (Online) (59)
Bookchapter (Online) (1)
OpenAccess-fulltext (62)
Sorted by: Relevance
Sorted by: Year
?
1
Predictive value on advance hodgkin lymphoma treatment outc..:
Biggi, Alberto
;
Chauvie, Stephane
;
Fallanca, Federico
...
Hematological Oncology. 41 (2023) 3 - p. 415-423 , 2023
Link:
https://doi.org/10.1002/..
?
2
Incorporating Monoclonal Antibodies into the First-Line Tre..:
Vassilakopoulos, Theodoros P.
;
Liaskas, Athanasios
;
Pereyra, Patricio
...
International Journal of Molecular Sciences. 24 (2023) 17 - p. 13187 , 2023
Link:
https://doi.org/10.3390/..
?
3
Revisiting the predictive role of 18F‐fluorodeoxyglucose po..:
Gallamini, Andrea
;
Sudria, Axel
;
Kurlapski, Michał
.
Hematological Oncology. 41 (2023) 4 - p. 608-611 , 2023
Link:
https://doi.org/10.1002/..
?
4
P004: Advanced stage classical Hodgkin lymphoma (cHL) patie..:
Viviani, Simonetta
;
Pavoni, Chiara
;
Barrington, Sally F.
...
HemaSphere. 6 (2022) - p. 2-3 , 2022
Link:
https://doi.org/10.1097/..
?
5
T021: Radiation-Free Therapy as the INitial treatment of Go..:
Gallamini, Andrea
;
Picardi, Marco
;
Filonenko, Kateryna
...
HemaSphere. 6 (2022) - p. 10-11 , 2022
Link:
https://doi.org/10.1097/..
?
6
P010: Inferior Outcomes for Young Adults Treated on Advance..:
Parsons, Susan K.
;
Rodday, Angie Mae
;
Friedberg, Jonathan W.
...
HemaSphere. 6 (2022) - p. 5-5 , 2022
Link:
https://doi.org/10.1097/..
?
7
Poster: HL-507 First-Line Brentuximab Vedotin Plus Chemothe..:
Straus, David
;
Radford, John
;
Connors, Joseph
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S161 , 2022
Link:
https://doi.org/10.1016/..
?
8
P009: Improved Overall Survival with First-Line Brentuximab..:
Hutchings, Martin
;
Ansell, Stephen M.
;
Connors, Joseph M.
...
HemaSphere. 6 (2022) - p. 4-5 , 2022
Link:
https://doi.org/10.1097/..
?
9
HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Imp..:
Straus, David
;
Radford, John
;
Connors, Joseph
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S350 , 2022
Link:
https://doi.org/10.1016/..
?
10
Myocardial Metabolic Response Predicts Chemotherapy Curativ..:
Marini, Cecilia
;
Bauckneht, Matteo
;
Borra, Anna
...
Biomedicines. 9 (2021) 8 - p. 971 , 2021
Link:
https://doi.org/10.3390/..
?
11
Brentuximab vedotin plus doxorubicin, vinblastine, and daca..:
Hutchings, Martin
;
Radford, John
;
Ansell, Stephen M.
...
Hematological Oncology. 39 (2021) 2 - p. 185-195 , 2021
Link:
https://doi.org/10.1002/..
?
12
Poster: HL-147: Brentuximab Vedotin with Chemotherapy for P..:
Ramchandren, Radhakrishnan
;
Długosz-Danecka, Monika
;
Connors, Joseph M.
...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S236 , 2021
Link:
https://doi.org/10.1016/..
?
13
FDG-PET/CT for the Management of Post-Chemotherapy Residual..:
Gallamini, Andrea
;
Kurlapski, Michał
;
Zaucha, Jan Maciej
Cancers. 13 (2021) 16 - p. 3952 , 2021
Link:
https://doi.org/10.3390/..
?
14
Dose-dense ABVD as first-line therapy in early-stage unfavo..:
Santoro, Armando
;
Mazza, Rita
;
Spina, Michele
...
Annals of Hematology. 100 (2021) 10 - p. 2547-2556 , 2021
Link:
https://doi.org/10.1007/..
?
15
Older patients (aged ≥60 years) with previously untreated a..:
Evens, Andrew M.
;
Connors, Joseph M.
;
Younes, Anas
...
Haematologica. 107 (2021) 5 - p. 1086-1094 , 2021
Link:
https://doi.org/10.3324/..
1-15